Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice

[1]  S. Alexopoulos,et al.  Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database , 2020, Clinical transplantation.

[2]  D. Häussinger,et al.  Transplanted Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Support Liver Regeneration in Gunn Rats. , 2018, Stem cells and development.

[3]  L. Zentilin,et al.  Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler–Najjar Syndrome Type I , 2017, Gene Therapy.

[4]  C. Tiribelli,et al.  Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment , 2017, Scientific Reports.

[5]  F. Orso,et al.  The RNA-binding protein ESRP1 promotes human colorectal cancer progression , 2016, Oncotarget.

[6]  L. Silengo,et al.  Prospects for Adult Stem Cells in the Treatment of Liver Diseases , 2016 .

[7]  P. Bosma,et al.  A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome , 2016, Molecular therapy. Methods & clinical development.

[8]  A. Flake,et al.  The Intravenous Route of Injection Optimizes Engraftment and Survival in the Murine Model of In Utero Hematopoietic Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  G. Novelli,et al.  Human induced pluripotent stem cells for monogenic disease modelling and therapy. , 2016, World journal of stem cells.

[10]  T. Bebee,et al.  ESRP2 controls an adult splicing programme in hepatocytes to support postnatal liver maturation , 2015, Nature Communications.

[11]  L. Silengo,et al.  Long Term Liver Engraftment of Functional Hepatocytes Obtained from Germline Cell-Derived Pluripotent Stem Cells , 2015, PloS one.

[12]  S. Strom,et al.  Amelioration of Hyperbilirubinemia in Gunn Rats after Transplantation of Human Induced Pluripotent Stem Cell-Derived Hepatocytes , 2015, Stem cell reports.

[13]  M. T. Donato,et al.  Human neonatal hepatocyte transplantation induces long‐term rescue of unconjugated hyperbilirubinemia in the Gunn rat , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  G. Camussi,et al.  Recellularization of rat liver scaffolds by human liver stem cells. , 2015, Tissue engineering. Part A.

[15]  G. Camussi,et al.  Human liver stem cells and derived extracellular vesicles improve recovery in a murine model of acute kidney injury , 2014, Stem Cell Research & Therapy.

[16]  M. Najimi,et al.  Human liver stem/progenitor cells decrease serum bilirubin in hyperbilirubinemic Gunn rat. , 2014, World journal of gastroenterology.

[17]  A. Muro,et al.  Generation of Ugt1-Deficient Murine Liver Cell Lines Using TALEN Technology , 2014, PloS one.

[18]  M. Giacca,et al.  Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome. , 2014, Human gene therapy.

[19]  A. Muro,et al.  Age-dependent pattern of cerebellar susceptibility to bilirubin neurotoxicity in vivo in mice , 2014, Disease Models & Mechanisms.

[20]  E. Sokal.  Treating inborn errors of liver metabolism with stem cells: current clinical development , 2014, Journal of Inherited Metabolic Disease.

[21]  J. Watchko,et al.  Bilirubin-induced neurologic damage--mechanisms and management approaches. , 2013, The New England journal of medicine.

[22]  Giuseppe Remuzzi,et al.  Monogenic diseases that can be cured by liver transplantation. , 2013, Journal of hepatology.

[23]  G. Camussi,et al.  Human liver stem cells improve liver injury in a model of fulminant liver failure , 2013, Hepatology.

[24]  M. Gómez-Lechón,et al.  Clinical Outcome of Hepatocyte Transplantation in Four Pediatric Patients with Inherited Metabolic Diseases , 2012, Cell transplantation.

[25]  L. Zentilin,et al.  Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  M. Schilsky,et al.  Liver transplantation for inherited metabolic disorders of the liver , 2010, Current opinion in organ transplantation.

[27]  J. Castell,et al.  Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies , 2010, Analytical and bioanalytical chemistry.

[28]  M. Weiss,et al.  Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens , 2008, Disease Models & Mechanisms.

[29]  M. Najimi,et al.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. , 2008, World journal of gastroenterology.

[30]  G. Pande,et al.  Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia. , 2008, Transplantation proceedings.

[31]  G. Camussi,et al.  Isolation and Characterization of a Stem Cell Population from Adult Human Liver , 2006, Stem cells.

[32]  V. Navarro,et al.  The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: An analysis of the OPTN database , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  R. Tukey,et al.  Tissue-specific, Inducible, and Hormonal Control of the Human UDP-Glucuronosyltransferase-1 (UGT1) Locus* , 2005, Journal of Biological Chemistry.

[34]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[35]  S. Strom,et al.  Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. , 1998, The New England journal of medicine.

[36]  C. Weiller,et al.  Ischemic stroke and incomplete infarction. , 1996, Stroke.

[37]  P. Bosma,et al.  Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. , 1994, The Journal of biological chemistry.

[38]  B. Rozdilsky,et al.  Crigler-Najjar syndrome in four of five siblings with postmortem findings in one. , 1970, Archives of pathology.

[39]  J. Crigler,et al.  Congenital familial nonhemolytic jaundice with kernicterus. , 1952, Pediatrics.

[40]  L. Silengo,et al.  Prospects for Adult Stem Cells in the Treatment of Liver Diseases. , 2016, Stem cells and development.